Dr. Olaf Hardt Lecture at Molecular Med Tri-Con 2016: Tumor Cell Isolation
Watch Dr. Olaf Hardt from Miltenyi Biotec R&D Oncology team describe a novel workflow for isolating pure tumor cell populations from primary tissue during last month’s TriCon2016 in San Francisco The Tumor Cell Isolation Kit, human enables the enrichment of human tumor cells from primary specimens using MACS® Cell Separation technology. While depleting tumor associated cells such as lymphocyte subpopulations, fibroblasts, and endothelial cells in a fast and easy protocol, the tumor cells remain untouched, improving any downstream analysis. Learn more http://goo.gl/Y2gZbO